Mylotarg allergy: Mylotarg (Gemtuzumab ozogamicin) was removed from the market in 2010 due to increased death rates over other treatment options. Over a ten year period it was used to treat . acute myelogenous leukemia. This article covers a list of potential adverse effects - many of which were severe: http://www.webmd.com/drugs/2/drug-19459/mylotarg-solution-reconstituted-recon-soln/details/list-sideeffects
Answered 5/19/2017
692 views
A doctor has provided 1 answer
A doctor has provided 1 answer
A doctor has provided 1 answer
A doctor has provided 1 answer
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question